Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Alcon Japan Aims to Be Leader in Glaucoma Treatment: President Kodama
October 14, 2002
- OTC NEWS IN BRIEF
October 14, 2002
- Korosho to Take Action to Materialize Industry Vision
October 14, 2002
- Yamanouchi Aims at \570 Bil. Sales in FY2004: President Takenaka
October 14, 2002
- Korosho Plan for Healthcare Reform to Be Presented by End of November
October 14, 2002
- Healthcare Expenditures Down 1.6% in 2nd QTR VS 1st QTR
October 14, 2002
- REGULATORY NEWS IN BRIEF
October 14, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 14, 2002
- Physician-led Trials to Start on New Indication for Irinotecan
October 14, 2002
- Korosho Pledges to Smoothly Implement New Blood Law
October 14, 2002
- Korosho to Give Priority to Useful Drugs in Clinical Trial Consultation
October 14, 2002
- New ADR Information System under Investigation
October 14, 2002
- BUSINESS NEWS IN BRIEF
October 14, 2002
- Sales Up, But Gross Profit Margin Down 4.14%: FJPWA Survey
October 7, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
October 7, 2002
- Effects of Generics Use-Promotion Policy Remain Unpredictable: EMA
October 7, 2002
- Iino in Saitama Joins AEON Welcia Group
October 7, 2002
- BUSINESS NEWS IN BRIEF
October 7, 2002
- Association to Support Studies of Health Food in Humans
October 7, 2002
- Health Minister Presents Personal Proposals for Healthcare Reform
October 7, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…